Merck related Press Releases
Celera Genomics Group-an Applera Corp. Business Grants License to Merck for Cancer Targets
Celera Genomics Group-an Applera Corp. Business Grants License to Merck for Cancer Targets /10/2008 ALAMEDA, Calif. -- Celera, an Applera Corporation business, today announced a two year exclusive Read more...
Experimental Weight-loss Drug Cuts Appetite, Burns More Energy, Study Suggests
Experimental Weight-loss Drug Cuts Appetite, Burns More Energy, Study Suggests The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose Read more...
Merck Sells Pennsylvania Chemicals Plant
Merck Sells Pennsylvania Chemicals Plant PHILADELPHIA, Jan. 1 -- PRWT Services, Inc., a minority-owned business enterprise, today announced that it has, through its wholly-owned subsidiary, Cherokee Read more...
PRESS RELEASE: Idera Pharmaceuticals, and Merck Forge $400 Million Cancer Drug Deal
Idera Pharmaceuticals, and Merck Forge $400 Million Cancer Drug Deal CAMBRIDGE, Mass. -- Idera Pharmaceuticals announced today that it has entered into a worldwide licensing and collaboration Read more...
PRESS RELEASE: Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB and COMVAX
Merck Announces Voluntary Recall of Certain Lots of PEDVAXHIB and COMVAX WHITEHOUSE STATION, N.J., Dec. 12, 2007 - Merck & Co., Inc. announced today that the Company has initiated a voluntary Read more...
PRESS RELEASE: Merck Reviews Progress on Strategic Plan at 2007 Annual Business Briefing
Merck Reviews Progress on Strategic Plan at 2007 Annual Business Briefing Merck's Pipeline Continues to Progress with Seven Products in Phase III Development Company Expects to File Applications Read more...
PRESS RELEASE: Merck Anticipates Earnings per Share Growth in 2008
Merck Anticipates Earnings per Share Growth in 2008; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding Certain Items Full-Year 2007 Anticipated non-GAAP EPS Read more...
PRESS RELEASE: GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR from Merck
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR from Merck Following FDA Approval, Agreement will Broaden Access to Cholesterol-Reducing Medicine PHILADELPHIA and WHITEHOUSE Read more...
PRESS RELEASE: Merck and Vertex Pharmaceuticals MK-0457 Trials Halted on Heart Risk
Merck and Vertex Pharmaceuticals MK-0457 Trials Halted on Heart Risk CAMBRIDGE, Mass. -- Vertex Pharmaceuticals Incorporated and Merck & Co., Inc. today provided an update to their Read more...
PRESS RELEASE: Nicholas Piramal Announces Drug Discovery and Development Agreement with Merck
Nicholas Piramal Announces Drug Discovery and Development Agreement with Merck Mumbai, India 19 November 2007: Nicholas Piramal India Limited and Merck & Co., Inc., which operates in India Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets

